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Introduction
Hepatitis C virus (HCV) continues to represent the
main causative agent of the hepatitis, which leads to
chronic transformation of the process in 60-80% indi-
viduals, except those infected with genotype 2 HCV in
Africa, which is cleared by 53% of individuals [1]. The
infection is induced by a virus carrying a positive-
sense single-stranded RNA genome that is about 10 kb
in length and encodes for a precursor polyprotein of
about 3,000 amino acids that is then cleaved into struc-
tural and nonstructural proteins [1,2]. Chronic hepati-
tis C is one of the major risk factor for the develop-
ment of liver cirrhosis and hepatocellular carcinoma
(HCC), but the mechanisms underlying liver damage
and the carcinogenic process are unclear [2]. In recent
years, studies in vitro have been focused on effects of
HCV genome products in control of hepatocyte prolif-
eration [3-7]. The potential members of the oncogene
group which might be involved in development of
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Abstract: Hepatitis C virus (HCV) continues to represent the main causative agent of the hepatitis, which leads to chronic
transformation of the process in 60-80% individuals. It remains unclear how far cellular expression of HCV proteins in vivo
may represent an index of progression of the disease and of proliferative activity in the liver in chronic hepatitis C. Aim of
the studies included detection and subcellular localization of three HCV proteins (NS3, NS5A and C) in liver biopsies from
adults (n=19) with chronic, long lasting hepatitis C as related to hepatocyte proliferative activity. The immunocytochemical
ABC (avidin biotin-peroxidase complex) technique was applied, alone or associated with the ImmunoMax technique.
Results of the immunocytochemical tests were compared to histological alterations in liver biopsies, proliferation index and
with selected clinical data. A significantly higher expression of NS3 protein was noted, as compared to expressions of NS5A
and C proteins. In all the patients, cytoplasmic localization of all proteins dominated over nuclear localization (p<0.05). At
the level of electron microscopy, protein localization in endoplasmic reticulum (ER) membranes, mitochondria, perinuclear
region and/or in hepatocyte cell nucleus was observed. No direct relationships could be demonstrated between expressions
of HCV proteins and of Ki-67 antigen. No correlations could also be demonstrated between cellular expression of any HCV
protein on one hand and grading or staging, alanine transaminase (ALT), serum level of HCV RNA or alpha-fetoprotein
(AFP) on the other. However, positive correlations were disclosed between proliferative activity of hepatocytes on one hand
and patient's age, grading and staging on the other. Advanced hepatic fibrosis correlated also with serum levels of AFP. The
studies were supplemented with data on subcellular localization of HCV proteins. Moreover, they indicated that in HCV
infection grading and staging, proliferative activity of hepatocytes and serum AFP level represent more valuable indices of
the disease progress than those provided by cellular expression of three potentially oncogenic HCV proteins in vivo. 
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HCC include at least three proteins of hepatitis C virus
(HCV), i.e. C (core, capsid), NS3 and NS5A proteins
[2,4,8]. All the three proteins might undergo transloca-
tion to cell nucleus acting as transcription activators
[2,9]. Involvement of the proteins was described in cell
cycle control, mediated by interactions with p21, p53
proteins and cyclins [3,5-7,10,11]. Some authors sug-
gest that steatosis poses an additional risk for HCC
[12]. HCV core protein plays an important role in the
development of hepatic steatosis in HCV infection by
stimulating expression of lipogenic enzyme genes and
fatty acid uptake associated protein [13]. Recent in
vitro studies provided a molecular explanation for
HCV genotype 3-specific lipid accumulation [14].
Apart from C protein, a direct role in neoplastic trans-
formation of hepatocytes in vivo and in vitro plays also
NS3 protein [6,15]. NS3 in a dose-dependent manner
specifically inhibits activity of p21/WAF1 promoter.
The effect is not cell specific and manifests synergy
with the effect of C protein [6]. NS5A protein repre-
sents a component of the complex of viral replicase,
localized on the cytosolic part of endoplasmic reticu-
lum [1,2,16]. Post-translational modifications result in
development of a protein form with lower molecular
weight, capable of translocation to the cell nucleus. This
protein form may act as a transcription activator. In the
virus/host interactions the protein exhibits a multidirec-
tional activity, influencing, among other, the cell growth
control [3,16,17]. Several results point to inter-relation-
ships between subcellular localization, molecular forms,
concentrations of the proteins in hepatocytes of patients
with chronic type C hepatitis and their effects on mech-
anisms linked to oncogenesis [15,18,19]. Controversies
as to localization of HCV proteins in chronic type C
hepatitis reflect, first of all, the difficulties in obtaining
an ideal model for studies on replication of HCV. In
most cases, both C protein and the non-structural pro-
teins (NS2-NS5) are associated with cellular organelles
in the cytoplasm (endoplasmic reticulum, mitochondria,
Golgi apparatus) and lipid droplets [20-23]. Moreover,
they have been localized in the perinuclear region and in
the cell nucleus itself [15,24]. 
Ki-67 expression in tumours has been shown to be
associated with prognosis in patients with hepatocellu-
lar carcinoma [25]. Application of MIB-1 antibodies
for testing of proliferative activity in the liver suggest-
ed that HCV infection induced increased and abnormal
hepatocyte proliferation, which might be related to the
increased risk of HCC in patients with HCV-related
liver damage [26]. Other HCC-associated variables in
patients with chronic viral hepatitis and cirrhosis are:
histological activity, platelet count and alpha-fetopro-
tein serum levels [27]. 
In this paper, in an attempt to further elucidate the
cellular expression of three HCV proteins (NS3, NS5A
and C protein) and hepatocellular proliferation, we
assessed the potential relationship between cellular
expression of the proteins and proliferative activity
and selected clinical data in a new series of 19
patients with chronic, long lasting (approximately 20
years) hepatitis C. 
Material and Methods
Human liver specimens. Studies were performed on 19 archival
biopsies of liver, obtained from adult patients with documented
chronic, long-lasting hepatitis C and with active replication of the
virus, confirmed serologically (all the patients were anti-HCV and
HCV RNA positive). The biopsies originated from patients of the
Department of Infectious Diseases and Chair of Gastroenterology
and Human Nutrition, Poznan University of Medical Sciences, in
whom the biopsies were performed in 2005-2006. All the patients
had negative serology for hepatitis B surface antigen (HBsAg) and
antibodies to human cytomegalovirus (HCMV), Epstein-Barr virus
(EBV), and human immunodeficiency virus (HIV) by standard
enzyme immunoassays (ELISA). Other cases of liver damage (e.g.
1-antitrypsin deficiency, Wilson's disease, alcohol dependency)
were ruled out. All the patients had abnormal serum alanine amino-
transferase (ALT) levels (normal level below 40 IU/l) for at least 6
months. All the patients were seropositive for antibody to HCV by
ELISA (HCV version 3.0 AXYM System, Abbott). Quantitation of
HCV RNA was conducted in 10/19 patients using AMPLICOR
HCVTM test, version 2.0 (ROCHE, Mannheim, Germany) with
sensitivity of 600 IU/ml. The test was standardized against the
WHO International Standard for HCV RNA. HCV genotyping was
carried out with INNO LiPa HCV II Assay (Innogenetics, Zwij-
naarde, Belgium) in 11/19 patients. Before liver biopsy none of the
patients was subjected to anti-viral therapy. At the time of biopsy
the mean age of patients (13 men and 6 women) was 46.7 ± 4.0
years (range: 19 to 74 years). At the time of liver biopsy, the mean
duration of HCV infection was 19.3 ± 2.3 years. 
The control group consisted of ten fragments of livers devoted
to organ grafting and obtained from serologically HCV, HBV,
CMV and EBV negative donors. Written informed consent was
obtained from each patient before liver biopsy, and approval for the
study was granted by the institution's Ethical Committee. 
Tissue preparation. Biopsy specimens were fixed in 10% forma-
lin, embedded in paraffin for purposes of light microscopy.
Histopathological lesions were evaluated, following the classical
H+E staining as well as silver technique and tri-chromate tech-
nique, according to Masson and periodic acid-Schiff with diastase
pretreatment. At least 10 sections were prepared from each biopsy
or from control liver fragments. Each tissue specimen was evalu-
ated basing on a numerical scoring system for the grade of por-
tal/periportal necroinflammation (G1=0-4), for the grade of lobular
necroinflammation (G2=0-4) and for the stage of fibrosis (S=0-4),
as proposed by Scheuer [28], and their sum (final grading,
G1+G2). The histological lesions considered to be characteristic of
chronic hepatitis were also evaluated. Histological evaluation was
performed independently by two experienced histopathologists.
For electron microscopy, the material was fixed in 2% glutaralde-
hyde (transmission electron microscopy) or 4% (v/v)
paraformaldehyde containing 0.2% (v/v) glutaraldehyde in 0.1M
phosphate buffer (pH=7.3) (immunoelectron microscopy). The
embedded in epon ultrathin sections were subjected to a conven-
tional electron microscopy and ultraimmunocytochemistry [22]. 
Immunocytochemistry. For immunocytochemistry 5 μm thick
sections were cut and mounted onto SuperFrost/Plus microscope
slides. Immunocytochemistry, using the mouse anti-NS3, anti-
NS5A proteins (NOVOCASTRA Labs.), and anti-capsid C protein
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(CHEMICON International, Inc.) monoclonal antibodies was per-
formed according to classical ABC (avidin-biotin-peroxidase com-
plex) technique alone or in association with the ImmunoMax tech-
nique [22,29]. For testing proliferative activity of hepatocytes
mouse anti-human Ki-67 monoclonal antibodies (clone MIB-1)
were used in dilution of 1:2 (DAKO). In ABC and ImmunoMax
techniques microwave-oven pretreatment for antigen retrieval was
used. In cases of three applied monoclonal antibodies against HCV
proteins the dilution of 1:50 proved to yield optimum results. In
ImmunoMax technique, the key reaction involved 8 min. incuba-
tion with biotinylated tyramine (1:50) at room temperature (Perk-
inElmer Life Sciences, Inc.). This was followed by another appli-
cation of streptavidin complex. The colour reaction was evoked
with the horse radish peroxidase substrate, 0.05% DAB in 0.05 M
Tris-HCl buffer, pH=7.6, supplemented with 0.001% H2O2. Posi-
tive reaction manifested, in at least three sequential sections, as a
dark brown or black precipitate in the cell nucleus and/or cyto-
plasm. Control reactions employed control sera of the respective
species in 0.05 M Tris-HCl, pH=7.6, supplemented with 0.1%
BSA and 15 mM sodium azide (negative control). 
Appropriate positive control for Ki-67 antigen expression
involved 5 tonsils with inflammatory lesions.
Immunoelectron microscopy. At the electron microscope level, the
immunocytochemical tests were preceded by examination of NS3,
NS5A and C protein expression in semithin sections, using ABC and
ImmunoMax techniques. Ultrathin section were subjected to
labelling with 15 nm colloidal gold-streptavidin (Biocell Int.,
Cardiff, UK). In each case, mouse MAbs were used in 1:50 dilution.
The negative control of the immunocytochemical reaction at the
level of electron microscopy involved substitution of primary anti-
bodies by a normal serum obtained from the same animal species as
the primary antibodies. Moreover, the company which produced the
antibodies (NOVOCASTRA, CHEMICON) warranted specificity
of the antibodies (ELISA tests, results of Western blot analysis).
Semiquantitative evaluation of the results and statistics. The con-
tents of NS3, NS5A and C proteins in liver biopsies obtained using
ImmunoMax technique were calculated by the semiquantitative
technique and reported as follows: 0=0% positive cells; 1=individ-
ual positive cells (<10%); 2=10-25% positive cells; 3=26-50% pos-
itive cells; 4=51-75% positive cells; 5=76-100% positive cells) [30],
evaluating 10 microscopic fields at magnification of 400×. The final
result represented mean score for the 10 fields. Expression of the
antigens was evaluated separately in the cytoplasm and in cell nucle-
us. Expression of Ki-67 proliferation-associated antigen (only clear-
ly labelled cell nuclei were considered), was calculated taking into
account mean proportion of immunopositive cells in 10 light micro-
scope fields. Positive nuclear staining was evaluated by counting a
total of at least 1000 cells. Expression was evaluated using the semi-
quantitative scale of Gatter et al. [31], in which the score of 1 corre-
sponded to up to 10% positive cells; the scores of 2, 3 and 4 corre-
sponded to 11-25%, 26-50% and ≥51% positive cells, respectively.
Fatty degeneration of liver was also semiquantitatively appraised,
scoring 0 when no steatosis was noted under a light microscope, and
annotating grades 1 or 2 when, respectively, <30% of hepatocytes or
30-70% of hepatocytes were affected [32].
All the preparations were examined under an OLYMPUS B-2
light microscope, at magnification ×400. 
In order to determine statistical significance of variations in the
expression intensity of the proteins (the results obtained in
ImmunoMax technique) and Ki-67 expression, we first calculated
the mean values of staining scores for liver biopsy groups. The
means were compared using the Mann-Whitney U test for non-
parametric independent data and the Wilcoxon test for non-para-
metric dependent data. Correlations between data rows were deter-
mined employing Spearman's rank correlation index. 
Results
Epidemiological, biochemical and virological data of
patients are summed up in Table 1.
Liver histology
All 19 liver biopsy samples of anti-HCV-positive
patients were diagnosed as manifesting histological
criteria typical of chronic type C hepatitis. Patients
with stage 3 and 4 fibrosis were combined into a group
with advanced fibrosis. The average stage of fibrosis
was 2.6±0.3. The average portal/periportal activity
(G1) was 1.9±0.2 and lobular (acinar) activity was
2.1±0.2; the sum of grading (G1+G2) was 4.0±0.4
(Table 2). In histological patterns large groups of lym-
phoid cells in the dilated portal spaces were observed
in individual patients. Infiltrates consisting of individ-
ual lymphoid cells or of their groups as well as traits
indicative of fibroblast proliferation were observed
also within hepatic lobules. Numerous biopsies
demonstrated enlarged hepatocytes, often with the evi-
dent fatty degeneration, involving the entire cell.
Numerous cells were observed with swollen, partially
vacuolised cytoplasm and individual cells showed
lysis. Cells with traits of cholestasis were also
observed. The most significant lesion in the entire
material involved pathology of hepatocyte nuclei
(their variable size and irregular shape, altered chro-
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Table 1. Epidemiological, biochemical and virological features of
chronic HCV infected patients.
Table 2. Histopathological scoring of chronic HCV infected
patients.
matic arrangement, numerous nucleoli, lesions in
nuclear envelope, frequent binary cell nuclei, variable
staining). 
In ultrastructure, numerous damaged mitochon-
dria, with a markedly more lucid, fine granular,
swollen matrix were frequently observed, with absent
or short cristae, the membranes of which formed
numerous horse-shoe shaped structures, frequently in
a direct contact with ER cisterns. The ER cisterns
were frequently widened, contained fine fibrillar
material and manifested only focal presence of ribo-
somes. Cell nuclei differed in size. Occasionally they
were markedly enlarged, with irregularly less com-
pact chromatin, large active nucleoli and formation of
perinucleolar network of filamentous structures. The
altered cell nuclei contained also sets of tubular struc-
tures.
In control liver biopsies, nonspecific changes were
noted, with individual cells of inflammatory infiltrate
in portal spaces, with no traits of liver fibrosis.
Immunocytochemical localization of HCV
proteins in the liver using ABC technique
Using ABC technique alone only NS3 protein was detect-
ed in all patients (n=19) but the reaction product was
poorly visible. In each case demonstration of the reaction
product required that the high temperature antigen
unmasking technique was employed. Microscope analy-
sis demonstrated cytoplasmic staining in a few hepato-
cytes near blood vessels or a diffuse cytoplasmic staining
in many hepatocytes in the entire field of hepatic lobule.
Using the classical ABC technique, neither NS5A nor C
protein could be detected in any of the patients.
Immunocytochemical localization of proteins 
in the liver using ABC technique combined with
ImmunoMax method
NS3 protein. Biotinylated tyramine amplification of
ABC technique permitted to detect NS3 protein in all
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Table 3. Histological findings and semiquantitative appraisal of Ki-67, NS3, NS5A and C proteins in liver biopsies of patients with chron-
ic hepatitis C. Designations: G1 - portal/periportal activity; G2 -grading in lobules; S - staging; a - score according to [28]; fatty degen-
eration score according to [32]; b - scoring system according to [31]; c - score: 0=0% cells; 1=individual positive cells (<10%); 2=10-25%
positive cells; 3=25-50% positive cells; 4=50-75% positive cells; 5=75-100% positive cells) [30]; the results are given in two numbers of
which the first denotes expression in cell nucleus and the other - cytoplasmic expression in hepatocytes; nt - not tested.
the examined liver biopsies (n=19). Cellular localiza-
tion of the protein resembled that documented using
the classical ABC technique. In the entire group of the
patients, a definite prevalence of cytoplasmic as com-
pared to nuclear localization of NS3 protein was noted
(Fig. 1A and 1B). The reaction product was much
more evident than that obtained with the use of unam-
plified ABC technique. The nuclear plus cytoplasmic
signal of NS3 protein presence was observed in indi-
vidual hepatocytes in a single liver biopsy specimen
(Table 3). No priviledged localization of NS3 protein
in hepatic lobules could be disclosed although the
immunopositive hepatocytes frequently were present
close to blood vessels or were present in groups. Pres-
ence of NS3 protein was demonstrated also in cells of
hepatic sinusoids (macrophages, endothelial cells) and
in individual cells of inflammatory infiltrates in portal
spaces of individual patients. In the entire group of
patients, more cells with a cytoplasmic presence of
NS3 protein were detected than cells with nuclear
localization of the protein (p=0.0001) (Table 4). 
NS5A protein. The ImmunoMax technique permitted
to detect NS5A protein in all the examined liver biop-
sies (n=15). As a rule, a cytoplasmic localization of the
protein was observed, which focally manifested a rel-
atively high intensity (Fig. 2A and 2B). In the entire
group of patients, more cells with a cytoplasmic pres-
ence of NS5A protein were detected than cells with
nuclear localization of the protein (p=0.001) (Table 4).
In three patients the nuclear localization was observed
only in individual cells (Fig. 2C). It should be stressed
that detection of NS5A protein in the studied clinical
material was possible only when the ImmunoMax
amplification was employed.
C protein. Presence of C protein was demonstrated in
17/19 patients. A cytoplasmic plus nuclear as well as
perinuclear expression of the protein was disclosed in
whole group of patients (Fig. 3A and 3B). The reaction
product was noted also in the cytoplasm of individual
cells in hepatic sinusoids and inflammatory infiltrates
of portal spaces. It should be stressed that detection of
C protein in the studied clinical material was possible
only when the ImmunoMax amplification was
employed. In the entire group of patients, more cells
with a cytoplasmic presence of C protein were detected
than cells with nuclear localization of the protein
(p=0.0004) (Table 4). Nuclear localization was observed
only in individual cells and in 6/19 biopsy specimens. 
NS3 and NS5A protein vs. C protein. Significantly
higher numbers of cells with NS3 protein expression
were detected as compared to cells with C protein
expression (p=0.0006) or cells containing NS5A pro-
tein (p=0.002). No significant differences could be dis-
closed between expression of C protein and that of
NS5A protein in the liver biopsy specimens (Table 4).
All the control reactions and reactions in control biop-
sy specimens yielded negative results.
Ki-67 antigen. Expression of  Ki-67 proliferation-
associated antigen was detected in liver biopsies of all
the patients. In most cases an intense nuclear reaction
was detected in hepatocytes and in individual cells of
inflammatory infiltrates (Fig. 4). In the semiquantita-
tive scale the mean cellular expression was 2.0±0.2.
No correlation could be noted between expressions of
Ki-67 antigen and of HCV proteins. However, a sig-
nificantly higher expression of Ki-67 antigen was doc-
umented in patients with liver cirrhosis as compared to
patients with no cirrhosis (p=0.01) (Table 5). Signifi-
cant positive correlations were detected between
expression of the antigen and patient's age (r=0.507;
p=0.045), portal/periportal grading (G1) (r=0.817;
p=0.0001), lobular activity (G2) (r=0.529; p=0.03),
final grading (G1+G2) (r=0.754; p=0.0007), and stag-
ing (r=0.644; p=0.007). A negative correlation was
noted between proliferative activity and duration of the
infection (r=-0.766, p=0.03). 
In the negative control material individual MIB-1-
positive cells were noted, as compared to numerous MIB-
1-positive lymphocytes in tonsillar lymphoid follicles.
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Table 4. Comparative immunocytochemical intensity of NS3,
NS5A and C protein in nuclear vs. cytoplasmic localization in
patients chronically infected with HCV (mean±SEM).
* - p=0.002 for  NS3 vs. NS5A; ** - p=0.0006 for NS3 vs. C protein.
Table 5. MIB-1 (Ki-67 antigen) labelled hepatocytes in patients
with or without cirrhosis by Scheuer score (mean±SEM). 
a - score according to [31]; 1=up to 10% positive cells; 2=11-25% positive
cells; 3=26-50% positive cells; 4=51-75% positive cells.
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Fig. 1. Fragments of hepatic lobules from patients with chronic, long lasting HCV infection. (A) Immunocytochemical localization of NS3 pro-
tein in hepatocytes in a semithin section. (B) NS3 protein in the cytoplasm of liver cells in stage 3 fibrosis. ABC-ImmunoMax technique. Hema-
toxylin counterstained (B). Original magnification ×400. Fig. 2. Fragments of hepatic lobules from patients with chronic, long lasting HCV
infection. (A) Very strongly immunopositive hepatocytes with NS5A protein and (B) NS5A protein dispersed between inflammatory infiltrate
cells, hepatocytes in the same patient as that in Fig. 1B. (C) Nuclear localization of NS5A protein in another patient with stage 4 fibrosis. ABC-
ImmunoMax technique. Hematoxylin counterstained. Original magnification ×400. Fig. 3. Fragments of hepatic lobules from patients with
chronic, long lasting HCV infection. (A) Immunocytochemical cytoplasmic localization of C protein. (B) Nuclear localization of C protein.
ABC-ImmunoMax technique. Hematoxylin counterstained (A). Original magnification ×400 (A), ×1000 (B). Fig. 4. MIB-1 (Ki-67 antigen)
positive nuclei of hepatocytes in patient with stage 3 fibrosis. ABC technique. Original magnification ×400.
Immunoelectron microscopy
Application of ABC technique to semithin sections con-
firmed expression and cellular localization of all proteins
and a more intense signal using ImmunoMax technique
(Fig. 1A). At the ultrastructural level, application of col-
loidal gold permitted to document the presence of NS3
and NS5A proteins frequently localized in dilated ER
cisternae, and also of enlarged mitochondria and cyto-
plasm (Fig. 5A-C). C protein was also mainly localized
in dilated ER cisternae, mitochondria, perinuclear region
and the cytoplasm of hepatocytes (Fig. 5D-F). We also
observed individual cell nuclei labeled with immuno-
gold, mostly detecting C protein (Fig. 5E and 5F).
Semiquantitative evaluation of NS3, NS5A and
C protein expression as compared to selected
histopathological and clinical data
In none of the patient significant correlation between
amounts of detected proteins and grading/staging, ALT
activity, AFP level, the length of infection or HCV RNA
level could be disclosed. Only in the case of NS5A pro-
tein a negative relationship could be documented
between expression of the protein and fatty degeneration
of the liver (r=-0.594, p=0.02). No significant reciprocal
relationships could be detected between expressions of
three HCV proteins in individual patients. 
Other correlations
The mean serum level of AFP in the studied patients
was 8.6±4.3 IU/ml. A significant positive correlation
was detected between serum concentration of AFP and
advancement of fibrosis (staging) (r=0.692, p=0.01).
No relationships could be noted between serum AFP
level and ALT activity, G1, G2, final grading (G1+G2)
or duration of the infection (p>0.05).
Discussion
Role of HCV proteins in oncogenesis of HCC remains
unclear. Studies at the tissue level continue on expression
of viral proteins and/or of HCV RNA, which might par-
ticipate in neoplastic transformation [4,5,6]. The last
decade brought several experimental proofs for partici-
pation of particularly three HCV proteins, i.e. core (C),
NS3 and of NS5A in the process of hepatocellular neo-
plastic transformation [2,5,6,16]. Debates continue on
cellular and subcellular localization of HCV proteins
[9,15,19,21,23]. Until now studies performed by our
team on expression of two HCV proteins (C and NS3) in
the chronic HCV infection in children, point to preva-
lence of cytoplasmic as compared to nuclear localization
of the two proteins in hepatocytes, which has been con-
firmed by ultrastructural studies. Presence of the two
proteins in a cell used to be accompanied by a significant
dilatation of endoplasmic reticulum cisternae and altered
mitochondria. The subcellular localization in the cell
nuclei and/or the perinuclear region has been observed
more frequently for C protein than for NS3 [22]. 
More frequent cytoplasmic than nuclear localisation
of the three HCV proteins observed by us at the level of
light microscopy is consistent with the literature data
even if the studies differ in the applied antibodies and in
tissue processing (paraffin vs. cryostat sections) [33,34].
Reports have also been published on unsuccessful
attempts to detect C protein and NS3 protein using non-
human antibodies [35]. In other studies a prevalence of
nuclear localization of HCV antigens has been detected
in patients with chronic type C hepatitis [24]. C protein
has been detected most frequently inside cytoplasm and
in association with ER membranes [36,37], but also in
lipid droplets [21,23] and in mitochondria [18,38].
Immunofluorescence studies have shown that the C pro-
tein colocalized with the E2 glycoprotein as well as with
a cellular ER membrane marker. There are also available
reports which do not confirm the mitochondrial localiza-
tion of C protein [21]. At the beginning, the nuclear
localization of C protein has been excluded in vivo [23],
suggesting only a potential for perinuclear localization
although subsequent studies have demonstrated two
forms of C protein and one of them (21 kDa) has been
present both in the cytoplasm and in the cell nucleus [9].
The nuclear localization has been confirmed also by
other authors [9,18,24]. Moreover, the nuclear localiza-
tion of C protein pertains an incomplete protein molecule
[19,39]. Relatively recent studies have identified a novel
bipartite nuclear localization signal (NLS), which
requires two out of three basic-residue clusters for effi-
cient nuclear translocation of C protein, possibly by
occupying binding sites on importin-α [18]. On the other
hand, no nuclear localization of C protein could have
been confirmed by immunofluorescence studies using a
confocal microscope and the Huh-7 cell line [21]. Earli-
er studies of our team have demonstrated C protein both
in hepatocyte cytoplasm and in individual cell nuclei.
The two localizations have been confirmed by electron
microscopy [22]. 
Our present ultrastructural observations indicate that
C protein in cytoplasm is present first of all in dilated cis-
ternae of ER and frequently in mitochondria. Thus, we
can confirm the suggestion on the role of C protein in
disturbing function of mitochondria, which leads to aug-
mented levels of free oxygen radicals and, thus, to lipid
peroxidation also in vivo [38]. Our earlier studies in
HCV infected children [22] and our present data on liv-
ers of patients with long-lasting HCV infection have
demonstrated mitochondrial localization of also NS3
protein, but significance of such localization has not
been closer recognized in in vitro studies. NS5A protein
detected by our team for the first time in vivo has been
observed mainly in the cytoplasm of hepatocytes and in
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individual cell nuclei of infected hepatocytes. All the
proteins which we discuss in this study have also been
noted in individual mononuclear cells of inflammatory
infiltrates. In this study a significantly more pronounced
expression of NS3 protein has been demonstrated, as
compared to expressions of NS5A and C protein, with
no differences between the latter two expressions. On
the average, slightly above 50% cells have been found
positive for NS3, which has exceeded proportions
observed by other authors (1-20%) [36]. Moreover,
detection of the remaining HCV proteins (C and NS5A)
has been observed only when the ImmunoMax tech-
nique has been applied. This corroborates our earlier
results on detection of HCV proteins [22]. In a given
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Fig. 5. Ultrastructural localization of NS3 (A, B), NS5A (C) and C proteins (D-F) in hepatocytes of patients chronically infected with
HCV. (A) Gold particles overlay mainly endoplasmic reticulum, cytoplasm and mitochondria. (B) Gold particles overlay mainly dilated
ER membranes surrounding mitochondria, mitochondria and cytoplasm. (C) Gold particles overlay mainly cytoplasm and ER. (D-E) Gold
particles overlay dilated ER surrounding mitochondria, mitochondria and cell nucleus structures. Streptavidin-colloidal gold. Original
magnification (A) ×20 000; (B) ×25 000; (C) ×30 000; (D) ×15 000; (E) ×20 000, (F) ×25 000.
patient, no correlation could have been disclosed
between expressions of the proteins. Also, the expres-
sion has shown no significant relationship to prolifera-
tive activity, evaluated by expression of Ki-67 antigen
nor to histopathological variables such as grading/stag-
ing and liver steatosis, except for the negative correla-
tion observed between expression of NS5A protein on
one hand and fatty degeneration on the other. We cannot
confirm the suggestions on the inducing role of C pro-
tein in lipid droplet accumulation in vivo [13], and the
association of NS5A and C proteins with lipid droplets
and apolipoprotein A1 [40]. Among our 11 patients with
HCV genotyping, 73% had HCV-1b infection. Some
recent in vitro observations suggest that liver steatosis is
related to genotype 3 HCV [14]. Expression of the stud-
ied HCV proteins has failed to correlate with age of the
patients, ALT activity, serum HCV RNA and AFP lev-
els, or duration of the infection. We observed the signif-
icant positive correlations have been noted between pro-
liferative index of hepatocytes and staging in the organ.
Thus, more pronounced expression of Ki-67 antigen has
been observed in patients with liver cirrhosis, as com-
pared to patients with less advanced fibrosis. In studies
of other authors positive correlations were documented
between proliferative activity and staging, but at the
stage 4 of fibrosis decreased expression of Ki-67 was
noted, suggesting an impairment of hepatic proliferation
in cirrhosis [41]. Our results have demonstrated no rela-
tionship between hepatocyte proliferative index and
serum AFP level, confirming the results of other authors
[41]. Similarly to present results, other authors detected
positive relationship between serum AFP levels and
extent of fibrosis in the liver [32,41,42]. Finally, this
study has shown positive correlation between expres-
sion of Ki-67 antigen on one hand and patient's age and
grading in the liver on the other. This is consistent with
observations of other authors who in HCV infected
patients demonstrated positive correlations between
numbers of Ki-67-positive cells on one hand and ALT
levels, Knodell index [26], older age, more severe
necroinflammation, and more severe fibrosis [41] on the
other. In patients with HCV more numerous Ki-67-pos-
itive cells were detected in the periportal area and in the
poorly proliferating perivenular area (zones 2 and 3)
[26]. In our results no differences in expression of Ki-67
antigen could have been detected between various
regions of the hepatic lobule. Similarly, no correlation
could have been detected between Ki-67 tissue expres-
sion and ALT activity. Similar results were obtained by
Canchis et al. [39] although some other authors have
detected such a relationship [26,43]. The negative cor-
relation between proliferative activity evaluated by
expression of Ki-67 antigen and duration of infection
has been surprising. In studies of other authors on
HCCs, patients with anti-HCV antibody had a lower
MIB-1 labeling index and better prognosis than HCC
patients negative for the antibody. However, there was
no significant correlation between anti-HCV antibody
and other proliferative parameters [44]. We cannot com-
ment on results of such studies since we have not exam-
ined patients with hepatocarcinoma. Nevertheless, it is
worth stressing that advancement of fibrosis represents
a more accurate index of the disease progress than dura-
tion of the infection. As many as two of the studied by
us variables (tissue expression of Ki-67 and serum AFP
level) have shown a direct relationship to staging. Other
authors have shown that also increased serum alpha-
fetoprotein levels were one of the HCC-associated vari-
ables in patients with virus-related hepatitis [27].
In conclusion, our microscopic analysis demonstrat-
ed cellular expression of NS3, NS5A and C proteins
mainly in the cytoplasm of infected hepatocytes in our
patients. Only in individual cells the nuclear presence of
the three proteins was noted. It should be stressed that
detection of all studied HCV proteins was possible in
our archival, paraffin-embedded material obtained from
immunocompetent patients with long lasting liver dis-
ease, independently of their detailed clinicopathological
data. As compared to the classical ABC technique, high-
er sensitivity of the ImmunoMax-amplified technique
was demonstrated, employing monoclonal antibodies for
detection of even small amounts of viral protein in the tis-
sue. Application of the technique significantly augmented
the potential for diagnosis of chronic type C hepatitis in
routinely sampled and fixed biopsy material. Our results
supplemented the data on subcellular localization of
HCV proteins. Moreover, they demonstrated that prolif-
erative activity of hepatocytes in vivo, intensity of fibro-
sis, grading and serum AFP level provide a more accurate
index of progression in HCV-induced liver disease as
compared to cellular expression of HCV proteins. 
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